Past Speakers

Justice

Delhi High Court

Justice Prathiba M. Singh completed her 5- year law course from University Law College, Bangalore. She graduated as the 1st Rank holder from Bangalore University and also represented India at the Philip C Jessup Moot Court competition in Chicago, USA. She was offered the ODASSS scholarship by the Cambridge Commonwealth Trust to study LL.M at the University of Cambridge (U.K.). She enrolled with the Bar in 1991.

Before being elevated to the Bench, she was a leading Intellectual Property lawyer in India. She had the distinction of handling landmark matters in all areas of IPR laws including patents, trademarks, designs, copyright, plant varieties, internet laws, etc. As Managing Partner of Singh & Singh, she advised clients and handled cases relating to commercial disputes, arbitration, telecom, broadcasting laws, media laws, writs, regulatory issues, education etc. She has regularly appeared before the Hon'ble Supreme Court of India, High Court of Delhi, TDSAT, IPAB, Trademark and Patent Offices. She was appointed as Amicus Curiae by the High Court of Delhi to streamline the working of the Copyright Office. She was also appointed on a High Level Committee for streamlining of Patent examinations.

She was invited as an expert to present views to the Parliamentary Committees considering amendments to the Patents Act in 2002, Copyright Amendment Act, 2012, Geographical Indications Act etc.

Mrs Singh was designated as a Senior Advocate by the Delhi High Court in December 2013.

The Prathiba M. Singh Scholarship for LL.M. students was instituted at the University of Cambridge in 2013. Scholarships are granted to Indian students who have secured admission at Cambridge, for pursuing their LLM course. Recently, she has been invited by the Vice Chancellor, Cambridge University to be part of the “Circle of Advisors” for India.

She was a member of the IPR Think Tank, which was entrusted with the momentous task of drafting India’s first `National IPR Policy’ which was released in May, 2015. She has also been awarded as “30 Most Powerful Business Women in India” Award by the Business Today Group in September 2018.

Her articles `India – Look behind the headlines’, `India is a game-changer in Patent laws’, `Implementation of the Commercial Courts Act’, `CRI guidelines’, ‘Expedited trials in patent cases’ etc., have been published in leading international and national publications.

During her tenure as the President of APAA (Indian Group), several important initiatives were taken including filing of a writ petition seeking constitution of the IPAB as also the creation of the Delhi court-room complex for the IPAB. She has been a regular Speaker at various National and International IP related workshops, seminars and events. She was also a member of the CII National Steering Committee on IPRs.

Various awards given to her include, ‘IP Litigator of the Year, 2012’, the ‘Asia women in Business Law Awards’ given by Managing IP for excellence in Litigation, ‘IP Lawyer of the Year, 2013’ by Legal Era, ‘Best IP Senior Counsel of the Year - 2014’ by Legal Era and ‘Woman Lawyer of the year, 2015’ by the Indian National Bar Association.

She was a Member of various professional bodies including SCBA, DHCBA, INTA, APAA, AIPPI, IPAA, IPLPA, and Telecom Lawyers Association.

She was elevated as a Permanent Judge of the High Court of Delhi on 15th May 2017.

IP management

Glenmark Pharmaceuticals Ltd.

Partner

AA Thornton

Deputy Chief Administrative Patent Judge, Patent Trial and Appeal Board (PTAB)

U.S. Patent and Trademark Office

The Honorable Jacqueline Wright Bonilla serves as Deputy Chief Administrative Patent Judge at the Patent Trial and Appeal Board (PTAB) at the U.S. Patent and Trademark Office. Since her appointment as an Administrative Patent Judge in January 2012, she has conducted numerous post-grant patent trials under the America Invents Act, heard appeals from adverse examiner decisions in patent applications and reexamination proceedings, and rendered decisions in interferences. In her current role, she helps lead the PTAB as it handles cases and renders decisions in all areas of its jurisdiction. Previously, she worked for twelve years in private practice, including as a partner at Foley & Lardner, LLP. She also served as a judicial law clerk to the now-retired Chief Judge Randall Rader at the U.S. Court of Appeals for the Federal Circuit. Judge Bonilla graduated from the University of Virginia School of Law, and holds a Ph.D. in Pharmacology from the University of Virginia, and a B.A. in Biochemistry from the University of California, Berkeley.

Director IPR

Dr. Reddy's Laboratories

Principal

R. K. Dewan & Co.

Head & Associate Vice President-Business Development, Portfolio & Strategy

Kashiv BioSciences LLC

Associate Partner

LexOrbis

Global General Counsel

Dr. Reddy's Laboratories

Leader Hatch-Waxman and Biosimilar Litigation Practice

McAndrews Held & Malloy

Aaron Barkoff leads the Hatch-Waxman and Biosimilar litigation practice at McAndrews. He has extensive first-chair trial experience in ANDA litigation. Over his 20-year career, he has represented clients ranging from the world’s largest pharmaceutical companies to start-ups, now focusing on generic and biosimilar companies. He has also represented both petitioners and patent owners in more than a dozen IPRs at the Patent Trial and Appeal Board.

Aaron is recognized in the IAM Patent 1000. IAM said he litigates “high-stakes patent infringement cases with poise.” It also noted that, “Innovative and thorough, Aaron has excellent writing and presentation skills, which go a long way towards the favorable outcomes he achieves; his style is systematic, convincing, and calm. He responds with incredible speed and communicates with you as if he’s across the table, not across the country.”

His strong technical background in biochemistry and biotechnology, combined with his deep understanding of FDA regulatory issues, enables him to provide life science companies with keen insights on patent litigation strategy. He also advises clients on Orange Book patent listings, patent term extensions, and FDA exclusivity.

Aaron is the founder and editor of Orange Book Blog, a widely-read blog reporting on developments at the intersection of patent and FDA law.

RECENT CASES

Amgen Inc. v. Amneal Pharms. LLC, et al., Nos. 16-853, 17-713 (D. Del.)
Lead trial counsel for Piramal Healthcare in ANDA litigation concerning Sensipar® (cinacalcet hydrochloride). Won trial verdict of non-infringement in 2018. Advised Piramal through at-risk launch in 2019. Won Federal Circuit affirmance of non-infringement in 2020. Won recovery of $33 million in lost-profit damages from Amgen in 2021.

Bial – Portela & CA, SA et al. v. Alkem Laboratories Ltd., Nos. 18-304, 20-786, 21-186 (D. Del.)
Lead trial counsel for Alkem Laboratories in ANDA litigation concerning Aptiom® (eslicarbazepine acetate). Trial scheduled for June 2022.

Tolmar Therapeutics, Inc. et al. v. Foresee Pharmaceuticals Co., Ltd., No. 21-15782 (D.N.J.)
Lead trial counsel for Foresee Pharmaceuticals in patent litigation concerning Foresee’s product CAMCEVI, a treatment for advanced prostate cancer. Case pending.

Astellas US LLC et al. v. Apotex Inc. et al., No. 18-1675 (D. Del.)
Lead trial counsel for Accord Healthcare in ANDA litigation regarding Lexiscan® (regadenoson). Case settled on terms favorable to Accord.

Sumitomo Dainippon Pharma Co., Ltd. et al. v. Piramal Healthcare UK Ltd., No. 18-13478 (D.N.J.)
Lead trial counsel for Piramal Healthcare in ANDA litigation concerning Latuda® (lurasidone hydrochloride). Case settled on terms favorable to Piramal.

Amgen Inc. et al. v. Accord BioPharma, No. 18-61828 (S.D. Fla.)
Lead trial counsel for Accord BioPharma in biosimilar litigation concerning Neupogen® (filgrastim) and Neulasta® (pegfilgrastim). Case settled on terms favorable to Accord.

EnviroLogix Inc. v. Ionian Technologies, LLC et al., Nos. IPR2018-00405 and -00406 (PTAB)
Lead IPR counsel for Ionian Technologies (Abbott Laboratories) concerning isothermal DNA amplification. Won decisions denying institution of IPR on all grounds.

Head IPR

Encube Ethicals Private Limited

Partner and Intellectual Property Department Chair

Locke Lord LLP

Partner

McAndrews, Held & Malloy Ltd

General Manager - Global IP

Zydus Cadila

General Manager - Global IP

Zydus Cadila

Partner

HGF

Chief IP Counsel - Global Head IPR

Biocon

Arshad Jamil is a senior Indian Patent Attorney with extensive experience in the legal and IP rights fields. Arshad is the Chief IP counsel and Global head of IP rights at Biocon Biologics, where he is responsible for the Biocon Group’s patent and trademark filings and policy, and handling Global litigation for Biosimilarsand ANDAs . Arshad manages Biocon group of companies IP portfolio of 1100+ global patents and 950+ global trademarks.

In his previous assignment,Arshad was a Senior Patent Attorney at Sun Pharma, where he handled ANDA litigations, including Hatch Waxman settlements. He received his Bachelor of engineering (B.E.) from Mysore University in 1991 and his Bachelor of Laws(LL.B.) from Meerut (CCS) University in 1998. In 2014 he completed the SP Jain Institute of Management and Research postgraduate executive management programme.Arshad is a distinguished speaker at National /International IP forums and recognised by IAM as The World’s leading IP strategists consecutively for 4 years 2017 ,2018, 2019, and 2020 editions of IAM strategy 300.

Sr Regional Manager and Head (IPFC & TISC)

National Research Development Corporation (DSIR Enterprise, Ministry of S&T, Govt. of India)

Former Chairman In-Charge & Technical Member-Patents Intellectual Property Appellate Board (IPAB) Department for Promotion of Industry and Internal Tr

Ministry of Commerce and Industry, Government of India.

General Manager - Global IP

Zydus Cadilla

Having more than 15 years of experience in the field of IntellectualProperty Rights (IPR) - especially Patents - associated withPharmaceutical formulation aspects.

Working on various IP aspects like:

• Infringement analysis / Freedom to operate analysis ofpharmaceutical formulations,
• Invalidation of formulation/method of use patents,
• Patent drafting and prosecuting in different patent officesthroughout the World, prior art search,
• New product selection for development - like FTF and earlyopportunity for entering in market,
• Due diligence of pharmaceutical products,
• Drug-device analysis (injectables),
• Discovery process (paper discovery and e-discovery).

Partner

AA Thornton

Partner

AA Thornton

Group General Counsel

Wockhardt Ltd

Sr.Vice President Legal and Group GC

Wockhardt

Ms. Debolina Partap, Sr.Vice President Legal and Group GC, Wockhardt, is a Gold Medalist in masters of law and has 28 years of experience in banking, finance, pharma and healthcare. She is responsible for all corporate legal work, M&As, IP and Litigation Management, legal compliance, transactions management amongst others. She advises top management on legal risks to the organization. She has contributed tremendously to Covid 19 vaccine contracts. Her main achievements come in settling complex financial cases and arbitrations filed against Wockhardt Limited, complex multi-jurisdictional arbitrations on commercial disputes and settling intricate derivatives suits filed against Wockhardt group globally. She is also handling legal issues pertaining to complex and composite global regulatory matters concerning Wockhardt Group. She is one of the few general counsels globally who handle forensics and data analytics. She and her team have won over 100 awards from internationally and nationally recognized legal organizations.

Patent Attorney

L.S.Davar & Co

Managing Partner

Pergament & Cepeda LLP

Partner

Rakoczy Molino Mazzochi Siwik LLP

Head & Patent Counsel Intellectual Property Management

Unichem labs

Partner

AA Thornton

Assistant Commissioner for Patents

USPTO

Chairperson, Fifth Board of Appeal

European Union Intellectual Property Office

Gordon Humphreys is currently Chairperson of the First Board and of the Third Board of Appeal at EUIPO, from 2014 to 2019 he had been Chairperson of the Fifth Board of Appeal, having joined the Boards as a Member in 2005. He was Head of the Register Service from 2002-2005 and joined EUIPO’s Legal Department in 1997. He is also an accredited mediator with the Chartered Institute of Arbitrators and is a member of the EUIPO Boards of Appeal Mediation Service since 2011.

Prior to working at EUIPO, Gordon was in private practice in Luxembourg and Brussels and qualified both as a barrister (England and Wales) and avocat (Brussels bar). He was also a member of the CIArb Sub-Committee on Revision of Mediation Rules between 2016 and 2018. Gordon was educated at the universities of Buckingham (LL.B), Cardiff (LL.M), Liège (masters in economic law) and Alicante (specialist en derecho de la Unión Europea).

Gordon speaks and writes regularly on ADR, trade mark and design matters, and has recently co-edited Mediation: Creating Value in International Intellectual Property Disputes, Wolters Kluwer (2018) and was a contributing author in Hasselblatt, Community Design Regulation: Article-by-Article Commentary, Second Edition (2018), Beck.

General Manager & Head - Global IP, Product Portfolio and Corporate Strategy

Panacea Biotec

Head of Intellectual Property

Novozymes

United States Intellectual Property Counselor for South Asia

United States Department of Commerce

.

Hetero Drugs

Senior IP Director

Questel

VP-IPM

Macleods Pharmaceuticals

Professor

NITIE

Vice President - IPM

Glenmark Pharmaceuticals

Sr. GM - IPR Legal

Mylan Laboratory

Partner

AA Thornton

Partner

Locke Lord LLP

Myoka “Miki” Goodin is a Partner based in the Chicago office of Locke Lord LLP and is a member of the Firm’s Executive Committee. Miki holds a Bachelor’s degree in Molecular and Cellular Biology from the University of California at Berkeley and obtained her law degree from the University of Southern California Gould School of Law. Miki focuses her practice on complex intellectual property litigation matters with a primary emphasis on disputes involving the Hatch-Waxman provisions of the Patent Act and the Federal Food, Drug and Cosmetic Act.  MikiGoodin has advised clients on regulatory issues before the U.S. Food and Drug Administration, has counseled and represented clients on various antitrust-related matters, including those relating to patent enforcement and settlement, and helps clients develop strategies for filing abbreviated or 505(b)(2) new drug applications.

Sr. GM - IP Speciality

Aurobindo

Dr. Nehal Bhatt has about 18 years of experience of working in the field of Intellectual Property in Pharmaceutical Industry. He is presently working as Senior General Manager, Intellectual property with focus on Speciality Products in Aurobindo Pharma Ltd, Hyderabad. He was associated with companies such as Amneal Pharmaceuticals, Actavis(was Allergan and now Teva), Glenmark Pharmaceuticals and Cadila Pharmaceuticals in past. He has been working in the areas of strategizing non-infringement or invalidity positions and litigation management for different geographies including US, EP and CA, patent filing and prosecution, IP due diligence for mergers and acquisitions, compliance of statutory obligations connected with PIV filings or 505b2 filings in US and MA filings in EU, product identification/selection support to strengthen company’s pipeline.

Dr. Nehal Bhatt is a pharmacy post-graduate from L.M.College of Pharmacy, PhD in Phamaceutical sciences and Post Graduate Diploma in Patent Law. He is a Registered Patent Agent. He has additionally a Diploma in Business Administration from ICFAI

Partner and Head IP of Patent – Design - Copyright Department

United Trademark & Patent Services

Partner in the Intellectual Property

Khaitan & Co.

Head IPR

Neuland Labs

Dr.P.S.R.C.Murthy is presently heading IPR department of Neuland Laboratories Limited, Hyderabad, earlier headed IPR department of Suven Life Sciences Ltd and worked as a Scientist in IPR department of Dr.Reddy’s Laboratories Ltd.

I am having rich, hands-on experience in all aspects of IP. Experience in handling IP for API’s, formulations, NCE’s and Peptides. With experience spanning over 19+ years, myself worked on all major IP concepts like IP creation, IP protection, IP commercialization, IP portfolio management, IP strategy, IP Litigation, IP licensing, Innovation management, Prosecution strategy for patents, creation of patent families for technology picket fencing, Ideation for 505(b)(2) opportunities, Patent drafting, Patent filing, Patent prosecutation, Negotiation and preparation of various IP related agreements, IP training and IPR team building.

Dr.P.S.R.C.Murthy is known as hardcore scientist and inventor, there are over 15 publications including patents, papers and posters.

Intiated and Implemented best IP practices in Dr.Reddy’s, Suven & Neuland Laboratories Ltd resulted lot of awards and saved crores of IP expenditure.

Education:

• Registered Patent Agent from Indian Patent Office.
• Ph.D (Pharmaceutical Chemistry), JNTU, Hyderabad
• M.Sc (Organic chemistry) from Andhra University, Visakhapatnam.
• Post Graduate Diploma in Patent Law from Nalsar University of Law, Hyderabad.
• Post Graduate Diploma in Chemical Analysis and Quality Management from Central University, Hyderabad.
• Post Graduate Diploma in Computer Sciecne from ECIL, Hyderabad.
• DL 101 course from WIPO.

Major Achievements:

• Won Malathion 505 b(2) Patent case in USA
• Sucessful outlicensed process for preparation of Malathion pharmaeutical use patent to Taro.
• Involved in granting of more than 1000 patent applications.
• Ranked one among the “Top 100 IP leaders of India” by WIPF.
• Received the “IP LeaderShip - 2020” award from Niti Aayog.
• Received the “IP Excellence - 2020” award from Niti Aayog.
• Received the “IP Gems of India - 2018” award from De science.
• Received the “IP Excellence in India - 2018” award from De science.
• Received the “Silver patent award - 2017” from Pharmaxacil, Government of India for achieving highest number of granted patents in area of Bulk drugs / API’s for Neuland Laboratories Ltd, Hyderabad.
• Received “Gold patent award – 2014” from Pharmaxacil, Government of India for achieving highest number of granted patents in area of API’s/NCE’s/Formulations for SUVEN Life Sciences Ltd, Hyderabad.
• Received the “Neuexcellence” award from Neuland Laboraties Ltd.
• Received the “Spark award” and Chairman’s appreciation letter from Dr.Reddy’s Laboratories Ltd.
• Received the “Valuable Employee” award from Suven Life Sciences Ltd.
• Received the “Quality management award” from Asian Paints (I) Ltd.
• Received the “Best teacher award” from Usha group of colleges.
• Received more 50 prizes in college and university level competitions
• Presented IP reaserch poster in ACS conference in March, 2012.
• Inventor for 8 patents, Co-Author for 5 publications and 2 posters.
• Invited speaker in national & international IP related conferences.
• Top ranker in Andhra University common entrance test.

Sr. Director & Head-Business Development

Portfolio & Strategy at Kashiv BioSciences LLC

Dr. Paras Vasanani is presently associated with Kashiv BioSciences LLC (US based innovator pharma company) as Sr. Director & Head Business development, Portfolio & Strategy.

Kashiv is a USA based pharma and biotech company working on Biosimilars, 505b2, NCEs & complex generics. Dr. Paras has started his career as IP professional from Alembic Pharma then Zydus Pharma then Amneal Pharma and currently working at Kashiv BioSciences with vast experience in the area of Intellectual Property Management, portfolio selection and business development activities. He has attended many litigations at US district court & CAFC in person. In the field of IP he has worked for various countries like USA, India, Europe, Canada, Mexico, Brazil and Australia.

Dr. Paras has pursued M.Pharm and Ph.D. with specialization in the field of Pharmaceutical Sciences from M.S.University, Vadodara. He did his MBA from IIM-Ahmedabad. He is registered Indian Patent Agent and Trademark Agent. He has more than 10 patents on his name as inventor. He remained as spoke person at various National & International Conferences, Symposiums and Universities.

Director, Head - IPR department

Neuland Laboratories Limited

Partner

Greenblum & Bernstein, P.L.C., USA

Paul A. Braier, Ph.D., Esq. (pbraier@gbpatent.com)
Partner
Greenblum & Bernstein, P.L.C., USA

Paul is a shareholder at G&B, and a member of the Pharmaceutical; Biotechnology; Litigation and Trial; and Client Counseling practice groups of Greenblum & Bernstein. His work in these groups includes preparing and supervising preparation of infringement and validity opinions, Notice Letters, litigation, and FDA citizen petitions, as well as general counseling, particularly in the pharmaceutical, chemical, and medical arts. Paul is involved extensively in the firm's pharmaceutical practice, and advises drug companies (primarily generics) on strategic planning and new product introduction. He works extensively with Hatch-Waxman issues and the interface of patent and FDA law. Paul travels throughout the world to meet with current and prospective clients, including regular visits to India.

Paul is a regular panelist in seminars given in association with the annual conferences of the Pharma IPR India conferences, and has spoken regularly at the International Generic Pharmaceutical Association and the European Generics Association and other conferences. Paul is an editor for the Journal of Generic Medicines and regularly contributes articles on patent law and generic drugs.

Paul received a Bachelor of Science in Chemistry with High Honors from the College of William and Mary in 1986, a Ph.D. in Chemistry from the University of Chicago in 1992, and a Juris Doctor degree from the Georgetown University Law Center in 1998. While at Georgetown University, Paul was a staff member of the Journal of Legal Ethics.

Paul is admitted to the Virginia State Bar, the U.S. District Court and Bankruptcy Courts for the District of Columbia, and the Court of Appeals for the Federal Circuit, and is registered to practice before the United States Patent and Trademark Office. Paul is a member of the American Intellectual Property Law Association, the American Bar Association, and the American Chemical Society.

Sr. Director (Head) - IP

Fresenius Kabi

Director (Head) - Intellectual Property Management

Fresenius Kabi Oncology Ltd

I am doctorate in Organic Chemistry, MBA and Law graduate. I am a Registered Indian Patent Agent with about 20 Years of experience in Leading Pharmaceutical Companies like Alembic, Ranbaxy (Presently Sun), Teva Pharmaceuticals and Fresenius Kabi Oncology Ltd.

I have more than 18 Years of experience as a Patent Professional and handled a wide sphere of Technological Areas of Patents – Chemistry, Polymorph, Formulations, Drug Delivery Systems, Indication, Biotechnology & Biosimilars, Medical devices and Nutrition. Currently I am responsible for all the Patent matters globally by supporting and Advising to the Research & Development, Business and Allied Functions of the Organization by ensuring hassle free product launch. Also exploring early market entry opportunities by designing around and challenging Road block Patents/applications. I handled drafting and prosecution of more than 200 Patent Applications. I am successfully involved in Indian opposition and Litigation of Patent matters. Also I work on identification of new and potential products, for the inclusion in product portfolio grid

Sr.Manager-Trademarks

Brand Protection, Sun Pharmaceutical Industries Limited.

General Counsel

Mankind Pharma Limited

Prateush has a rich corporate experience of 17-years stint with Indian Customs, four years with Viraj Profiles and a further four years with the law firms MV Kini and Co and Kochar and Co. At Indian Customs, where he began his career in 1991, Prateush was instrumental in setting up the first private port and CFs.

At Viraj Profiles Limited, the world’s leading manufacturer of stainless steel long products, Prateush’s portfolio included legal and regulatory matters, taxation, strategy planning, liaising and coordination, statutory compliances, labour matters, contracts, agreements and acquisitions. He was responsible for health checks and internal and statutory audits. He acted as a bridge and point of contact between all supporting functions and businesses for resolving issues and risk mitigation. He liaised with government agencies and ministries at the state and Centre. His tenure with MV Kini and Co and Kochar and Co saw him handling regulatory representation and litigation, providing advice on antidumping matters, statutory compliances and the setting up and de-bonding of SEZ, STPI and EOU.

In his present position as General Counsel, Chief Risk and Compliance Officer at Mankind Pharma Limited, Prateush has been instrumental in the successful closure of all critical litigation. He has also been effective in handling litigation pertaining to a wide range of statutes relating to the pharmaceutical industry as well as Tax, Employment, Corporate and Anti-Trust laws.

Patent Director

HGF

Head IP - Product Portfolio

Hikal Ltd

Partner

Remfry & Sagar

Ph.D., Partner

Taft Stettinius & Hollister LLP

Partner

Upadhye Tang LLP

General Manager- IPM

Glenmark Pharmaceuticals Ltd

Shradha Saraf is currently with Glenmark Pharmaceuticals limited. Prior to Glenmark, she was associated with LupinPharma and Sun Pharma.Shradha’s background combines a post graduate degree in pharmaceutics from NIPER (National Institute of Pharmaceutical Education & Research), Mohali with more than 17 years of industry experience.

Among other things Shradha’s key area of focus includes FTO assessment& design IP strategies across various Regulated and Semi regulated markets with primary focus on North American market. She has IPR experience in both innovative and generic segments which includes small molecules, biologicals, drug device, respiratory, oncologyand all kind of generic, complex generic or super generics. Her expertise also includes managing Hatch Waxman litigations in collaboration with the Counsel.

Sr. General Manager & Head – Corporate IP

Piramal Pharma Global

Experience: 26+ years (16+ years in Corporate IP and prior 10 years as research scientist in Medicinal Chemistry)

• Experience in patent related and legal matters pertaining to various functions / businesses such as API- Intermediates, API (drug substance), Formulation (drug product), New chemical entities, Phytocare (Herbal), Medical devices, Critical care, OTC products and Glass
• Expertise in advising on IP strategy and providing sustainable end-to-end solutions to facilitate evaluation and development of patentable and non-infringing opportunities in different business areas, aligned with the respective business strategy
• Robust patent drafting and strong prosecution skills.; expertise in using various databases; IP due diligence
• Developing IP strategy for generic launch from product selection to market launch by identifying PIII/PIV opportunities
• Experience in handling trademark and copyright portfolio end-to-end for all businesses.

Qualifications:

• Degree in Law (recipient of four gold medals)
• Masters in Organic Chemistry
• Certified Indian Patent Agent.
• Diploma in Patents Law
• Diploma in International Business Development
• ASCEND Entrepreneur Graduate- 1 year In-house leadership training

Key Responsibilities:

• Patent support for strategic molecule selection, patent certifications, non-infringing/invalidation strategy for PIV certifications, section 8 label carve-outs & trade dress evaluation. trademark & copyright portfolio.
• Drafting and filing of robust patent applications world-wide.
• Prosecuting patent applications world-wide to obtain patent grants.
• Providing non-infringement, patentability, freedom to operate, invalidity and other legal opinions.
• Competitive intelligence, landscaping, due-diligence, out-licensing and advising in on-going litigations, providing techno-legal advice.
• Patent portfolio management & Operational excellence initiatives.

Achievements:

• Powerful Women in IP-2021 by WIPF in Mar 2021
• NITI Aayog award for excellent leadership in field of Patents-2020
• Featured in Top 100 IP Leaders of India 2018 by World IP Forum
• Woman leader in Innovation awarded in 2019
• IDMA Team Award 2016 and 2017
• Best Use of IP in Innovation team award-2019 Transformance Forums
• IP Gem of India awarded in 2018 and 2019 by Questel.
• Invited speaker in academic forums- National Conf. on "Academia, Industry Collaboration-Opportunities & Challenges".
• Authored articles in The Pharma Review, entitled:
  • Working Statements in Indian Patent System-A Balance of Interests
  • Challenges in generic drug development
  • Drug price control mechanisms in the Indian Patent Act
  • Optimizing the patent portfolio in a pharmaceutical set-up
  • Jurisdictional patent damages-US and India

Partner

Locke Lord LLP

Partner

S. MAJUMDAR & CO

Asst. Principal Attorney - Chemical Department

L. S. Davar & Co.

HOD - Intellectual Property Management

Glenmark Life Sciences

Senior IP Consultant

Indoco Remedies Ltd

Swati is an accomplished IP expert. In her career spanning over 26 years, she has been involved in strategic patent portfolio management; drafting and prosecuting over 500 world-wide patent applications; providing legal opinions on patentability, patent infringement, FTO analysis and validity issues, and devising strategies for patent litigation.

Currently, in her role as Senior IP Consultant at Indoco Remedies Ltd., Swati provides strategic expertise on a broad range of IP issues, advises senior management on IP issues that have legal implications, prepares opinions and deals with IP litigations. Prior to joining Indoco, Swati served as In-House Patent Counsel and Head of Patents Dept. at Piramal Healthcare Ltd. overlooking protection of inventions in Drug Discovery Research, process chemistry and formulations. During her tenure, Piramal won Pharmexcil “Platinum Patent Award” in 2014, for securing the most number of patents under overall category. She has also worked as patent professional for leading Indian Pharmaceuticals including Sun Pharma. and Lupin.

Swati is a frequent speaker on emerging areas of patent law at various events. Recognised among “Powerful Women in IP - India 2021” by World Intellectual Property Forum. In the year 2019, Swati received recognition as “IP Star Woman of the Year” from Legal Era Magazine. Also, received recognition amongst “Top 100 Powerful Women in Law” by World Intellectual Property Forum in the year 2017.

Vice Prresident and Head Portfolio Planning and IP Litigtaion

Sun Pharma

Dr. Taranpreet Singh Lamba is presently working as Vice President of Intellectual Property and Product Portfolio Management in Glenmark Pharmaceuticals Limited, Mumbai. He has more than 19years of rich experience in the patent matters with specific focus in managing patent portfolios, infringement analysis and litigations for various geographies like US, EP, India and Emerging Markets. He is also a Head of Product Portfolio in Glenmark for making future pipeline for key regulated markets including US, Europe.

Dr. Taranpreet Singh Lamba is a pharmacy graduate and has done M. Tech in Pharmaceutical Technology from NIPER and has further also done specialization in patent law.

Associate

Locke Lord LLP

Speaker Details